333 related articles for article (PubMed ID: 16077188)
1. Cyclic GMP metabolism and its role in brain physiology.
Domek-Łopacińska K; Strosznajder JB
J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():15-34. PubMed ID: 16077188
[TBL] [Abstract][Full Text] [Related]
2. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
Geng Y; Zhou L; Thompson WJ; Lotz M
J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
[TBL] [Abstract][Full Text] [Related]
4. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo.
Kleiman RJ; Chapin DS; Christoffersen C; Freeman J; Fonseca KR; Geoghegan KF; Grimwood S; Guanowsky V; Hajós M; Harms JF; Helal CJ; Hoffmann WE; Kocan GP; Majchrzak MJ; McGinnis D; McLean S; Menniti FS; Nelson F; Roof R; Schmidt AW; Seymour PA; Stephenson DT; Tingley FD; Vanase-Frawley M; Verhoest PR; Schmidt CJ
J Pharmacol Exp Ther; 2012 May; 341(2):396-409. PubMed ID: 22328573
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of cyclic GMP in peritoneal macrophages of rat and guinea pig.
Kobiałka M; Witwicka H; Siednienko J; Gorczyca WA
Acta Biochim Pol; 2003; 50(3):837-48. PubMed ID: 14515164
[TBL] [Abstract][Full Text] [Related]
7. Characterization of nitric oxide synthase, soluble guanylyl cyclase, and Ca2+/calmodulin-stimulated cGMP phosphodiesterase as components of neuronal signal transduction.
Mayer B; Koesling D; Böhme E
Adv Second Messenger Phosphoprotein Res; 1993; 28():111-9. PubMed ID: 7691122
[No Abstract] [Full Text] [Related]
8. Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.
Witwicka H; Kobiałka M; Siednienko J; Mitkiewicz M; Gorczyca WA
Biochim Biophys Acta; 2007 Feb; 1773(2):209-18. PubMed ID: 17141339
[TBL] [Abstract][Full Text] [Related]
9. Localization of natriuretic peptides and their activation of particulate guanylate cyclase and nitric oxide synthase in the retina.
Blute TA; Lee HK; Huffmaster T; Haverkamp S; Eldred WD
J Comp Neurol; 2000 Sep; 424(4):689-700. PubMed ID: 10931490
[TBL] [Abstract][Full Text] [Related]
10. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
11. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour.
Kleppisch T; Feil R
Handb Exp Pharmacol; 2009; (191):549-79. PubMed ID: 19089345
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
[TBL] [Abstract][Full Text] [Related]
13. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
14. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
15. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
[TBL] [Abstract][Full Text] [Related]
16. Regulation of guanosine 3':5'-cyclic monophosphate in ovine tracheal epithelial cells.
Range SP; Holland ED; Basten GP; Knox AJ
Br J Pharmacol; 1997 Apr; 120(7):1249-54. PubMed ID: 9105699
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
[TBL] [Abstract][Full Text] [Related]
18. Traumatic injury of the spinal cord and nitric oxide.
Marsala J; Orendácová J; Lukácová N; Vanický I
Prog Brain Res; 2007; 161():171-83. PubMed ID: 17618976
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase G-mediated stimulation of basal Leydig cell steroidogenesis.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1399-408. PubMed ID: 17848628
[TBL] [Abstract][Full Text] [Related]
20. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
